Adult vaccines 2023-2024
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 75D30123D16730
- Awardee
-
Pfizer Inc. UEI MHBQULRMEEJ5
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Task orders
- 0
Award facts
- Opportunity
-
- 2023 Vaccines for Adults (VFA) Solicitation · 75D30123R72730 · Posted Apr 5, 2023
- Last date to order 100% complete
- IDV ceiling
- $103,060,230.33
- Maximum order
- $103,060,230.33
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 7 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Centers for Disease Control and Prevention (CDC) has awarded Pfizer Inc. an Indefinite Delivery Contract (IDC) for the supply of various adult vaccines to support immunization programs under Section 317(j) of the Public Health Service Act. The $103,060,230.33 contract, which runs from July 1, 2023 to June 30, 2024, covers a range of vaccines including hepatitis A, hepatitis B, pneumococcal polysaccharide, tetanus and diphtheria toxoids, herpes zoster, measles-mumps-rubella, meningococcal conjugate, human papillomavirus, and others. The contract has no set-aside designation, reflecting Pfizer's status as a large pharmaceutical manufacturer. The vaccines will be delivered within 15 business days of order receipt and shipped F.O.B. destination, as directed by delivery orders, to support adult immunization programs through the CDC and state health departments.
The original solicitation sought proposals for an IDIQ contract to supply these adult vaccines to the CDC's National Center for Immunization and Respiratory Diseases. The solicitation specified minimum and maximum order quantities for each vaccine type, with an estimated 1.5 to 3 million total doses across 12 different vaccines. Proposals were due by April 19, 2023, with inquiries accepted until April 12, 2023. The contract is being awarded under FAR Part 12 and Part 15 procedures for the purchase of commercial items.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$6,170 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $858,331 | |
| Funding Only Action | $928,090 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $470,453 | |
| Supplemental Agreement for work within scope | $1,111,643 | |
| Original award | $282,365 |
Quick answers
Who was awarded contract 75D30123D16730?
75D30123D16730 was awarded to Pfizer Inc. by CDC Pittsburgh (Centers for Disease Control and Prevention) on July 1, 2023.
How much is contract 75D30123D16730 worth?
75D30123D16730's own ceiling is $103,060,230. A single order can be worth up to $103,060,230.
Who can order from contract 75D30123D16730?
75D30123D16730 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75D30123D16730 competed?
The extent of competition for 75D30123D16730 was full and open competition. The government received 7 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV